Tove Agner

Tove Agner

Professor emeritus.

Member of:

  • Dermatovenerology


  1. 2022
  2. Published

    Skin barrier response to active chlorine hand disinfectant - An experimental study comparing skin barrier response to active chlorine hand disinfectant and alcohol-based hand rub on healthy skin and eczematous skin

    Yüksel, Y. T., Sonne, M., Nørreslet, L. B., Gundersen, G., Fazli, M. M. & Agner, Tove, 2022, In: Skin Research and Technology. 28, 1, p. 89-97 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Systemic treatment of children and adolescents with atopic dermatitis aged ≥2 years: a Delphi consensus project mapping expert opinion in Northern Europe

    de Graaf, M., Janmohamed, S. R., Schuttelaar, M. L. A., Agner, Tove, Alfonso, J. H., De Schepper, S., Deleuran, M., Despontin, K., Elenius, V., Ghislain, P. D., Huilaja, L., Johansson, E. K., Kvenshagen, B. K., Mandelin, J. M., Olset, H., Svensson, A., van Tuyll van Serooskerken, A. M., Thyssen, Jacob Pontoppidan & Vestergaard, C., 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 11, p. 2153-2165

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Temporal and Spatial Variation of the Skin-Associated Bacteria from Healthy Participants and Atopic Dermatitis Patients

    Barnes, Christopher James, Clausen, M., Asplund, M., Rasmussen, Linett, Olesen, C. M., Yüsel, Y. T., Andersen, P. S., Litman, Thomas, Hansen, Anders Johannes & Agner, Tove, 2022, In: mSphere. 7, 1, 14 p., e00917-21.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial

    Worm, M., Thyssen, Jacob Pontoppidan, Schliemann, S., Bauer, A., Shi, V. Y., Ehst, B., Tillmann, S., Korn, S., Resen, K. & Agner, Tove, 2022, In: British Journal of Dermatology. 187, 1, p. 42-51 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Time for a change

    Agner, Tove & Goossens, A., 2022, In: British Journal of Dermatology. 186, 2, p. 212-213 2 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  7. Published

    Topical corticosteroids reduce the density of Staphylococcus aureus in hand eczema

    Nørreslet, L. B., Edslev, S. M., Bregnhøj, A., Sommerlund, M., Ebbehøj, N. E., Andersen, P. S. & Agner, Tove, 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 4, p. e318-e319 2 p.

    Research output: Contribution to journalLetterResearchpeer-review

  8. Published

    Validation of the Danish version of the Quality of Life in Hand Eczema Questionnaire (QOLHEQ)

    Yüksel, Y. T., Ibler, Kristina Sophie, Agner, Tove & Ofenloch, R., 2022, In: British Journal of Dermatology. 187, 2, p. 256-258 3 p.

    Research output: Contribution to journalComment/debateResearchpeer-review

  9. Published

    An update on the prevalence and risk exposures associated with hand eczema in Danish hospital employees: A cross-sectional questionnaire-based study

    Yüksel, Y. T., Ebbehøj, N. E. & Agner, Tove, Feb 2022, In: Contact Dermatitis. 86, 2, p. 89-97 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Hand eczema, wet work exposure, and quality of life in health care workers in Denmark during the COVID-19 pandemic

    Yüksel, Y. T., Nørreslet, L. B., Flachs, E. M., Ebbehøj, N. E. & Agner, Tove, Jun 2022, In: JAAD International. 7, p. 86-94 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 Next

ID: 919101